Cardiovascular (cv) Risk Clinical Trials
2 recruiting trials for Cardiovascular (cv) Risk. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Cardiovascular (cv) Risk clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1), Jérôme Bouchan (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Aerobic exercise program (behavioral, 1 trial), followed by Therapeutic education.
Track Cardiovascular (cv) Risk trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Cardiovascular Risk Assessment in Young Women After Index Pregnancy With and Without Placental Complications
In this project, the investigators aim to study how all these factors determine the cardiovascular status of a total of 1,800 mothers, 3 to 6 years after delivery. In addition,...
Effects of an Aerobic Exercise Program on Cardiovascular Risk in Patients With Chronic Kidney Disease or Rheumatoid...
The goal of this clinical trial is to determine whether an aerobic exercise program can reduce cardiovascular risk in patients with systemic inflammation, such as those with...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Cardiovascular (cv) Risk, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Cardiovascular (cv) Risk, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Cardiovascular (cv) Risk, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.